Grape skin extract versus placebo in patients with metabolic syndrome and insulin resistance. A double blind, randomized, multicenter study.

• Conditions: metabolic syndrome; Metabolic and Endocrine - Other metabolic disorders

• Registration Number: ACTRN12610000458033
• Lead Sponsor: Ache Laboratories

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2010-06-04
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 128

Inclusion Criteria

diagnosis of metabolic syndrome
homeostasis model assessment of insulin resistance [HOMA-IR] >2,7

Exclusion Criteria

hypertension (stages 2 and 3)
diabetes

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
insulin resistance measured by the homeostasis model assessment of insulin resistance [HOMA-IR] index[all visits]

Secondary Outcome Measures

Name	Time	Method
blood pressure (using a calibrated sphygmomanometer)[all visits];lipids: high-density lipoprotein [HDL-c], low-density lipoprotein [LDL-c], total cholesterol, triglycerides (blood analysis)[all visits]